CNSX:CRL Charles River Laboratories International (CRL) Stock Price, News & Analysis → The Gold Grab of the Century (From Colonial Metals) (Ad) Free CRL Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume34,000 shsAverage Volume33,785 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Charles River Laboratories International alerts: Email Address Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy About Charles River Laboratories International Stock (CNSX:CRL)Carl Data Solutions Inc. operates as an industrial internet of things and big data as a service company in Canada and the United States. It operates in three segments: Data Services, Data Hosting, and Sale of Environmental Sensors. The company offers collection, storage, and analytic solutions for data-centric organizations. It also provides solutions that are deployed at municipal reservoirs and water treatment facilities for work camps and temporary communities. In addition, the company offers analytics tools used to predict weather events that cause combined sewer overflow; and solutions that integrate with SCADA systems and historical data to predict flooding and other possible risks to infrastructure. Further, it provides industrial solid waste monitoring solution for the construction sector; industrially robust sensors and industrial IoT gateways; and wireless networking that offers real-time monitoring of bins. Additionally, the company offers sensor networking for pipeline strain, wireless mesh networks, slope stability monitoring for stream and river crossings, and sensors that measure water saturation and slope stability. The company was formerly known as Carl Capital Corp. and changed its name to Carl Data Solutions Inc. in October 2015. Carl Data Solutions Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.Read More Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy CRL Stock News HeadlinesApril 18, 2024 | stockhouse.comNotice to Long-Term Charles River Laboratories International, Inc. (CRL) Shareholders: Grabar Law Office Is Investigating Claims on Your BehalfApril 4, 2024 | stockhouse.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Charles River Laboratories International, Inc. (CRL)April 25, 2024 | Insider Financial (Ad)Thousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.April 1, 2024 | finance.yahoo.comCharles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024March 14, 2024 | finance.yahoo.comCharles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing CollaborationMarch 7, 2024 | finance.yahoo.comCalculating The Fair Value Of Charles River Laboratories International, Inc. (NYSE:CRL)March 2, 2024 | finance.yahoo.comInsider Sell: EVP & Chief People Officer Victoria Creamer Sells 5,000 Shares of Charles ...March 1, 2024 | msn.comCharles River Labs stock hits 52-week highApril 25, 2024 | Insider Financial (Ad)Thousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.February 16, 2024 | seekingalpha.comCharles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold'February 16, 2024 | markets.businessinsider.comEvercore ISI Remains a Buy on Charles River Labs (CRL)February 14, 2024 | msn.comCharles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On WednesdayFebruary 14, 2024 | finance.yahoo.comCharles River (CRL) Q4 Earnings Surpass, Margins ContractFebruary 14, 2024 | finance.yahoo.comCharles River (CRL) Reports Q4 Earnings: What Key Metrics Have to SayFebruary 14, 2024 | finance.yahoo.comCharles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 GuidanceFebruary 9, 2024 | finance.yahoo.comUnveiling Charles River (CRL) Q4 Outlook: Wall Street Estimates for Key MetricsJanuary 23, 2024 | finance.yahoo.comCharles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference CallJanuary 18, 2024 | finance.yahoo.comCharles River's (CRL) New Launch to Boost Gene Therapy ProgramsJanuary 10, 2024 | markets.businessinsider.comMaintaining Buy on Charles River Labs: Unwarranted Downturn Presents Attractive Entry PointDecember 19, 2023 | ca.finance.yahoo.comCRL May 2024 290.000 callDecember 19, 2023 | ca.finance.yahoo.comCRL Feb 2024 90.000 callDecember 12, 2023 | finance.yahoo.comCharles River Finalizes Agreement with CELLphenomics, Expanding 3D In Vitro Services for Cancer Therapy Drug ScreeningNovember 30, 2023 | finance.yahoo.comCharles River (CRL) Gains on Price & Volume Growth Amid FX WoeNovember 22, 2023 | finance.yahoo.comInsider Buying: Corporate Executive VP & COO Birgit Girshick Acquires Shares of Charles ...November 21, 2023 | finance.yahoo.comCharles River Laboratories International, Inc.: Charles River Earnings: Cautious Client Spending Affects Near Term, but Long-Term Outlook PositiveNovember 16, 2023 | finance.yahoo.comCharles River Introduces CliniPrime Cryopreserved Leukopaks, Expanding Suite of GMP-Compliant Cellular ProductsNovember 13, 2023 | finance.yahoo.comCharles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and OncologySee More Headlines Receive CRL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Charles River Laboratories International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolCNSX:CRL CUSIPN/A CIKN/A Webcarlsolutions.com Phone+1-778-3790275FaxN/AEmployees18,400Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Jean-Charles PhaneufCEO & DirectorMr. David Gregory Johnston (Age 54)Pres Comp: $160kMr. Brian Cale Thomas BA (Age 53)MBA, Chief Financial Officer Comp: $127kMr. Trent KaminsAccount Mang.Mr. Piotr StepinskiChief Technology OfficerMr. Nathan Edward RudykDirector of Corp. CommunicationsMr. Kevin B. Marsh (Age 57)Pres of FlowWorks More ExecutivesKey CompetitorsBiomark DiagnosticsCNSX:BUX45525 (CUR.TO)TSE:CURAbattis BioceuticalsCNSX:ATTAgraflora Organics InternationalCNSX:AGRAAmplify Alternative Harvest ETFCNSX:MJView All Competitors CRL Stock Analysis - Frequently Asked Questions How do I buy shares of Charles River Laboratories International? Shares of CRL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:CRL) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
